Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89. Review.

2.

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Blennow K, Hampel H, Weiner M, Zetterberg H.

Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16. Review.

PMID:
20157306
3.

Antioxidants and aging: NMR-based evidence of improved skeletal muscle perfusion and energetics.

Wray DW, Nishiyama SK, Monnet A, Wary C, Duteil SS, Carlier PG, Richardson RS.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1870-5. doi: 10.1152/ajpheart.00709.2009. Epub 2009 Sep 18.

4.

Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Harrison FE, Allard J, Bixler R, Usoh C, Li L, May JM, McDonald MP.

Nutr Neurosci. 2009 Oct;12(5):203-18. doi: 10.1179/147683009X423364.

5.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.

6.

The role of nutrition in Alzheimer's disease: epidemiological evidence.

Morris MC.

Eur J Neurol. 2009 Sep;16 Suppl 1:1-7. doi: 10.1111/j.1468-1331.2009.02735.x. Review.

7.

Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.

Siedlak SL, Casadesus G, Webber KM, Pappolla MA, Atwood CS, Smith MA, Perry G.

Free Radic Res. 2009 Feb;43(2):156-64. doi: 10.1080/10715760802644694.

8.

The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches.

Cotman CW, Head E.

J Alzheimers Dis. 2008 Dec;15(4):685-707. Review.

PMID:
19096165
9.

Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease.

Wadsworth TL, Bishop JA, Pappu AS, Woltjer RL, Quinn JF.

J Alzheimers Dis. 2008 Jun;14(2):225-34.

10.

Biochemical markers in persons with preclinical familial Alzheimer disease.

Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL.

Neurology. 2008 Jul 8;71(2):85-92. doi: 10.1212/01.wnl.0000303973.71803.81. Epub 2008 May 28.

PMID:
18509095
11.

Coenzyme Q10 attenuates beta-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation.

Yang X, Yang Y, Li G, Wang J, Yang ES.

J Mol Neurosci. 2008 Feb;34(2):165-71. doi: 10.1007/s12031-007-9033-7. Epub 2008 Jan 5.

PMID:
18181031
12.

Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis.

Hager K, Kenklies M, McAfoose J, Engel J, Münch G.

J Neural Transm Suppl. 2007;(72):189-93.

PMID:
17982894
13.

Oxidative damage in mild cognitive impairment and early Alzheimer's disease.

Lovell MA, Markesbery WR.

J Neurosci Res. 2007 Nov 1;85(14):3036-40. Review.

PMID:
17510979
14.

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

Blennow K, Zetterberg H, Minthon L, Lannfelt L, Strid S, Annas P, Basun H, Andreasen N.

Neurosci Lett. 2007 May 23;419(1):18-22. Epub 2007 Apr 6.

PMID:
17482358
15.

Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.

Garcia-Alloza M, Dodwell SA, Meyer-Luehmann M, Hyman BT, Bacskai BJ.

J Neuropathol Exp Neurol. 2006 Nov;65(11):1082-9.

PMID:
17086105
16.

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

Bateman RJ, Munsell LY, Morris JC, Swarm R, Yarasheski KE, Holtzman DM.

Nat Med. 2006 Jul;12(7):856-61. Epub 2006 Jun 25.

17.

The role of biomarkers in clinical trials for Alzheimer disease.

Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):6-15. Review.

18.

Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice.

Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW Jr.

Neurobiol Aging. 2007 Feb;28(2):213-25. Epub 2006 Jan 31.

PMID:
16448723
19.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group.

N Engl J Med. 2005 Jun 9;352(23):2379-88. Epub 2005 Apr 13.

20.

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K.

Clin Chem. 2005 Feb;51(2):336-45. Epub 2004 Nov 24.

Supplemental Content

Support Center